FDA logs recall of Victory Medical Center Pharmacy semaglutide-carnitine vials in three states
An enforcement-report entry shows a pharmacy-supplied semaglutide and L-carnitine multi-dose product is being withdrawn, but it gives no volumes, so the commercial impact cannot be sized.
11 Nov 2026 · FDA enforcement report · Regulator
A semaglutide and L-carnitine injection supplied by Victory Medical Center Pharmacy is the subject of a recall entered in the US Food and Drug Administration's enforcement report dated 11 November 2026. The record carries the reference D-0139-2027 and shows the action as still open.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on CompePharma and VigiEye
- One subscription for both sites, cancel any time
or
Official record: FDA enforcement report ↗
Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.
More Manufacturing & supplyAll →
Manufacturing & supply
Health Canada lists Class II recall of Stryker's Blueprint shoulder-planning software over two bugs
18 Nov 2026 · Health Canada · Regulator
Manufacturing & supply
Teleflex recalls PICC kits and spring-wire guides over coating detachment risk, Health Canada reports
18 Nov 2026 · Health Canada · Regulator
Manufacturing & supply
Health Canada: Raz Design recalls shower commode chairs over seats that can break
18 Nov 2026 · Health Canada · Regulator
Manufacturing & supply
Lantern Pharma opens first TNBC trial site, starts HARMONIC Part 2 in Taiwan; CEO resigns
18 Nov 2026 · Lantern Pharma Inc. LTRN · Company news
Manufacturing & supply
OXB confirms manufacturing deal with Aura Biosciences for bel-sar Phase 3 and commercial supply
17 Nov 2026 · OXB · Company news
Manufacturing & supply
Diagnostica Stago recalls lot of STHEMO DDi M, Dutch inspectorate notice shows
17 Nov 2026 · IGJ · Regulator